Contents
Remote cardiac monitoring fraud can turn a physician’s order into a more expensive claim, charge for ECG analysis performed by unqualified offshore technicians, or use referral payments to buy the next patient’s business. The mismatch can sit in an enrollment screen, a diagnostic code, a technician’s work queue or a discounted service agreement. If you work in a monitoring center, cardiology practice, sales team or billing department, you may know which version of the service the company actually delivered.
A cardiac monitoring portal that defaults to a more expensive service can change what gets billed even when the physician’s instructions are clear. In the LifeWatch and BioTelemetry portal case, the government alleged that enrollment choices steered patients into higher-paying telemetry despite physicians’ intent to order a cheaper service.
The device’s capabilities, the menu selection and the physician’s order could point in different directions. A clinic’s enrollment note is particularly revealing because it records what the physician wanted before the claim went out.
The difference between Holter monitoring, event monitoring and mobile cardiac telemetry changes both the work and the payment.
A whistleblower’s complaint against MedNet, a remote cardiac monitoring company, describes Holter monitoring as a continuous recording returned for analysis after the recording period. It describes event monitors that activate when a patient experiences symptoms or when an algorithm detects an event. Mobile telemetry transmits recorded segments to a remote technician for review and possible physician notification.
The Justice Department’s CardioNet account describes mobile cardiac outpatient telemetry as continuous recording with data sent by cellular technology to a diagnostic center. Its LifeWatch account describes ambulatory cardiac telemetry as recording cardiac events in real time without the patient having to press a button. The ordered test, the work performed and the monitoring report explain what the service actually involved.
A monitoring supplier may provide the device, connectivity and portal. A treating professional assesses the patient and orders care. A management company may handle staffing and billing. The brand on the screen, the person reading the data and the entity submitting the claim can be different participants. We trace the work through those participants to see where the billed description changed.
Earlier LifeWatch and CardioNet cases alleged that inaccurate diagnosis codes made higher-priced telemetry appear payable. The medical-necessity story changed on the claim.
The LifeWatch complaints alleged that the company used a false diagnostic code to obtain Medicare payment for telemetry supplied to patients with only mild or moderate palpitations. In the CardioNet case, the government alleged that less expensive monitors could effectively collect the needed data for those patients.
The historical price difference explains the incentive. During the period described in the Justice Department’s 2012 LifeWatch announcement, Medicare reimbursed ambulatory cardiac telemetry at between $750 and $1,200, compared with roughly $250 for traditional event monitoring.
For someone inside enrollment or billing, these cases make the diagnosis history consequential. The patient record explains the symptoms. The claim says why the selected test should be paid. Instructions about which diagnosis to use can connect those records to the decision inside the business.
The BioTelemetry and CardioNet offshore case concerned federal-program cardiac tests allegedly reviewed in India, often by unqualified technicians. The location of the technical work and the qualifications of the people performing it were separate payment questions.
A second amended whistleblower complaint against BioTelemetry and CardioNet also alleged that software replaced technician review:
Defendants have systemically relied on computer algorithms to analyze the data in an attempt to reduce staffing.
The next paragraph describes the alleged result at the diagnostic testing facilities:
However, the computer algorithms are not accurate and the IDTFs are producing false, automatically-generated reports without any personal review or visual oversight by a technician.
That allegation puts a specific question behind a finished report: who actually reviewed the underlying data?
For an insider, the useful comparison runs from the work queue to the report and claim. Routing and access records can identify where analysis occurred. Staffing and credential records identify who was available to perform it. A report bearing a domestic location then has to be understood alongside the work that produced it. We examine what each reviewer did and which service the claim represented.
In cardiac monitoring, a kickback can take the form of a financial benefit offered to induce referrals, including free staff or a profitable billing arrangement. The MedNet case shows why the payment can be embedded in the service contract.
In the MedNet referral case, the government alleged that customers billed Medicare for MedNet’s monitoring work and kept the difference between reimbursement and the company’s fee as an inducement to refer patients. The whistleblower’s complaint separately alleged that favorable private-insurer billing terms secured federal-program referrals.
The LifeWatch and BioTelemetry settlements also required reviews of how claims and referrals were handled. Those obligations identify another place an insider may have seen discrepancies raised inside the company.
LifeWatch’s five-year corporate integrity agreement announced in 2012 included executive certifications and monitoring of claim submissions, sales-force activities and certain referral relationships. BioTelemetry’s five-year agreement announced in 2022 required risk assessment, internal review and an independent annual assessment of medical necessity and claims billed to Medicare.
The BioTelemetry agreement’s claims review connects the monitoring order with company records and the ordering practitioner’s records. For an employee who worked on those reviews, the exceptions, supporting documents and response inside the company can add context to the original billing decision. A clinical instruction, a portal selection and a paid claim may have been compared before the whistleblower ever contacted anyone outside the business.
Medicare pays for qualifying remote patient monitoring through separate components for setup and education, device supply and treatment management. General remote patient monitoring has its own code family, separate from the cardiac diagnostic services in the LifeWatch and CardioNet cases.
CMS says general remote patient monitoring does not require an order or ordering-provider information on the claim. That makes the actual patient and service records particularly useful when examining enrollment. The LifeWatch portal allegations concern the different cardiac diagnostic service chain and what physicians intended to order. Remote patient monitoring enrollment and device billing depend on the requirements for that service and date.
Remote patient monitoring concerns include unnecessary enrollment, missing device training, absent monitoring, unsupported staff time and overlapping claims. The inspector general’s monitoring report describes unsolicited calls, texts and advertisements followed by enrollment and billing even when monitoring never occurs.
Remote monitoring time and duplicate billing raise separate questions about patient-specific work, required contact and overlapping claims. RPM and remote therapeutic monitoring cannot be billed together for the same patient and period. Qualifying chronic care management can coexist with RPM only when time and effort are not counted twice.
These are useful comparisons for a cardiac practice that also bills general monitoring. The cardiac inquiry still follows the selected test, medical need, technical work, report and referral arrangement. We connect the records across that chain with the person who knows how the operation ran.
If you know why the enrollment, ECG review or referral payment differed from the service billed, speak with our whistleblower experts about the cardiac monitoring operation. We work beside you throughout the case, build your strongest account of those decisions and bring in health care fraud whistleblower lawyers who understand cardiac diagnostics, technical billing and referral arrangements. A whistleblower case under the False Claims Act can pay 15% to 30% of what the government recovers.